---
figid: PMC7216262__ijms-21-02718-g002
figlink: pmc/articles/PMC7216262/figure/ijms-21-02718-f002/
number: F2
caption: 'This figure illustrates the ways in which activity from the mTOR signaling
  pathway contributes to appendage (a) or muscle regeneration (b,c): (a) Concerning
  appendage regeneration, the Wnt/β-catenin pathway and insulin-like growth factor
  (IGF-1) activate mTORC1. This activity leads to the wound covering, blastema formation
  and regenerative outgrowth of the appendage. (b) During muscle regeneration, mTORC1
  activity is necessary for myofiber growth but not myogenesis. mTORC1 inhibition
  by rapamycin treatment inhibits regeneration whereas the leucine amino acid, insulin-like
  growth factor 1 or Akt activity contribute to mTORC1-mediated muscle regeneration.
  SPAR regulatory protein (small regulatory polypeptide of amino acid response) can
  inhibit mTORC1 activity and hinder muscle regeneration. (c) mTORC1 signaling is
  necessary for muscle regeneration in the injured limb and to induce a Galert state
  in the contralateral limb. The Galert cells enter the cell cycle more rapidly and
  show an increase in size compared to quiescent satellite cells.'
pmcid: PMC7216262
papertitle: mTOR Signaling at the Crossroad between Metazoan Regeneration and Human
  Diseases.
reftext: Yasmine Lund-Ricard, et al. Int J Mol Sci. 2020 Apr;21(8):2718.
pmc_ranked_result_index: '944'
pathway_score: 0.905423
filename: ijms-21-02718-g002.jpg
figtitle: mTOR Signaling at the Crossroad between Metazoan Regeneration and Human
  Diseases
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7216262__ijms-21-02718-g002.html
  '@type': Dataset
  description: 'This figure illustrates the ways in which activity from the mTOR signaling
    pathway contributes to appendage (a) or muscle regeneration (b,c): (a) Concerning
    appendage regeneration, the Wnt/β-catenin pathway and insulin-like growth factor
    (IGF-1) activate mTORC1. This activity leads to the wound covering, blastema formation
    and regenerative outgrowth of the appendage. (b) During muscle regeneration, mTORC1
    activity is necessary for myofiber growth but not myogenesis. mTORC1 inhibition
    by rapamycin treatment inhibits regeneration whereas the leucine amino acid, insulin-like
    growth factor 1 or Akt activity contribute to mTORC1-mediated muscle regeneration.
    SPAR regulatory protein (small regulatory polypeptide of amino acid response)
    can inhibit mTORC1 activity and hinder muscle regeneration. (c) mTORC1 signaling
    is necessary for muscle regeneration in the injured limb and to induce a Galert
    state in the contralateral limb. The Galert cells enter the cell cycle more rapidly
    and show an increase in size compared to quiescent satellite cells.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT5A
  - WNT6
  - WNT7A
  - WNT8A
  - WNT8B
  - WNT10B
  - WNT2B
  - WNT16
  - WNT2
  - WNT3
  - WNT7B
  - WNT11
  - WNT9A
  - WNT9B
  - WNT4
  - WNT10A
  - WNT5B
  - WNT3A
  - AKT2
  - AKT3
  - AKT1
  - SPAAR
  - Amino acid
  - Leucine
  - Rapamycin
genes:
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: SPAR
  symbol: SPAR
  source: hgnc_alias_symbol
  hgnc_symbol: SPAAR
  entrez: '158376'
chemicals:
- word: Amino acid
  source: MESH
  identifier: D000596
- word: Leucine
  source: MESH
  identifier: C038361
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases: []
figid_alias: PMC7216262__F2
redirect_from: /figures/PMC7216262__F2
figtype: Figure
---
